Abstract
The issues of prevention and treatment of infections of the genitourinary system are important not only for urologists and nephrologists, but also for general practitioners. It is the primary care physicians, in the first place, that help this category of patients. The article presents the results of studying the efficacy, safety and tolerability of Levofloxacin, as well as its effect on clinical course and laboratory parameters in empirical antibacterial therapy of patients with acute infections of the genitourinary system. The results obtained demonstrate high clinical and bacteriological efficacy, good tolerability and safety of levofloxacin in patients of this group. Relatively low cost and affordability makes it possible to recommend levofloxacin as an antibacterial first line drug for empirical antibacterial therapy of urinary tract infections in the practice of family doctors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
